Halozyme Therapeutics HALO Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $312.01M+76.9% | $136.42M+17.8% | $419.67M+172% | $61.86M-67.1% | $176.33M+7.1% | ||
| $2.26M— | $2.6M— | —— | —— | $0— | ||
| $457.99M+50.6% | $426.27M+47.9% | $343.54M+25.8% | $315.07M+49.7% | $304.03M+64.1% | ||
| $14.84M-55.6% | $20.77M-62.4% | $29.6M-48.6% | $32.08M+2.7% | $33.44M-80.2% | ||
| $21.9M+18.9% | $21.87M-8.9% | $18.96M-38.0% | $17.79M-34.7% | $18.42M-36.7% | ||
| $35.04M-4.4% | $30.92M+2.5% | $34.84M+134% | $30.93M-15.7% | $36.65M-16.0% | ||
| $113.37M-20.9% | $144.45M+1.1% | $161.59M+12.6% | $164.87M+30.2% | $143.24M+49.5% | ||
| $70.96M+59.0% | $64.64M+65.9% | $94.96M+118% | $76.65M-9.7% | $44.62M-2.3% | ||
| $8.87M-98.0% | $9M-97.1% | $251.44M-16.6% | $373.25M+22.5% | $440.89M+87.6% | ||
| $400K-63.6% | —— | —— | —— | $1.1M-15.4% | ||
| $1B-20.5% | $825.21M-24.0% | $1.33B+17.9% | $1.12B+13.7% | $1.26B+44.5% | ||
| $46.93M+16.7% | $44.44M+8.8% | $40.58M+1.5% | $39.6M-1.5% | $40.22M-4.0% | ||
| $35.22M+29.3% | $33.16M+30.4% | $31.06M+30.4% | $29.21M+31.3% | $27.23M+28.6% | ||
| —— | —— | $30.85M-10.6% | $31.92M-8.3% | $32.59M-9.9% | ||
| $582.32M+39.7% | $580.36M+39.2% | $416.82M0.0% | $416.82M0.0% | $416.82M0.0% | ||
| $951.96M+184% | $981.47M+144% | $299.84M-19.2% | $317.61M-18.3% | $335.37M-17.5% | ||
| $47.53M+816% | $42.92M— | $8.22M-31.2% | $20.21M+48.1% | $5.19M+743% | ||
| $15.29M+3.8% | $10.93M-37.2% | $17.95M+8.3% | $21.38M+0.4% | $14.73M+13.7% | ||
| $0-100% | $0-100% | $30.85M-85.4% | $113.07M+210% | $130.71M+105% | ||
| $2.67B+21.7% | $2.53B+22.4% | $2.22B+4.9% | $2.05B+4.3% | $2.2B+19.3% | ||
| $14.1M-29.8% | $20.9M+104% | $15.36M+23.9% | $18.69M+21.1% | $20.07M+50.6% | ||
| $94.6M+230% | $104.35M+298% | $56.16M+92.2% | $62.04M+214% | $28.64M+37.4% | ||
| $18.14M+75.4% | $28.62M+17.3% | $15.83M-9.2% | $12.37M-1.6% | $10.34M-1.0% | ||
| $5.7M+613% | —— | $0-100% | $0-100% | $800K-33.3% | ||
| $208.74M— | $0— | $710.69M— | —— | —— | ||
| $32.42M+10.3% | $34.57M+12.6% | $28.1M-8.6% | $28.97M-5.5% | $29.39M-7.5% | ||
| $32.95M+258% | $35.48M+243% | $8.37M-8.3% | $8.37M+72.4% | $9.21M+101% | ||
| $48.01M-17.2% | $44.15M+42.4% | $26.02M+640% | $24.96M-14.7% | $57.96M+204% | ||
| $363.21M+142% | $177.09M+27.3% | $837.23M+669% | $134.28M+0.7% | $150.38M+14.2% | ||
| $1.94B+28.4% | $2.14B+42.3% | $800.07M-46.8% | $1.51B+0.4% | $1.51B+0.4% | ||
| $32.42M+10.3% | $34.57M+12.6% | $28.1M-8.6% | $28.97M-5.5% | $29.39M-7.5% | ||
| $106.45M+88.6% | $113.86M+108% | $71.8M+77.7% | $77.77M+155% | $56.44M+80.9% | ||
| $2.45B+43.1% | $2.48B+45.7% | $1.72B+3.1% | $1.72B+2.4% | $1.71B+3.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| 300M0.0% | 300M+243,802% | 300M0.0% | 300M0.0% | 300M0.0% | ||
| $27.39M+261% | $12M— | $23.91M-61.4% | $0-100% | $7.6M-35.6% | ||
| $204.84M-57.1% | $54.79M-84.8% | $502.15M+26.3% | $361.03M+38.5% | $477.96M+186% | ||
| -$12.7M-272% | -$18.09M-572% | -$22.26M-221% | -$28.4M-1,273% | -$3.41M-130% | ||
| $219.64M-54.5% | $48.81M-86.6% | $503.92M+11.3% | $332.75M+15.0% | $482.27M+171% | ||
| $2.67B+21.7% | $2.53B+22.4% | $2.22B+4.9% | $2.05B+4.3% | $2.2B+19.3% | ||
| $8.87M-98.4% | $9M-98.1% | $282.3M-44.9% | $486.32M+42.5% | $571.59M+91.3% | ||
| $8.88M-98.4% | $9M-98.1% | $282.04M-44.8% | $486.37M+42.4% | $571.61M+91.2% | ||
| $8.9M-97.4% | —— | $63M-14.9% | $280.8M-11.0% | $340.9M+58.2% | ||
| $8.9M-97.4% | —— | $63M-14.9% | $280.8M-11.0% | $340.9M+58.2% | ||
| $457.99M+50.3% | $441.27M+43.1% | $346.04M+21.1% | $316.34M+47.5% | $304.62M+55.5% | ||
| $8.87M-98.4% | $9M-98.1% | $282.3M-44.9% | $486.32M+42.5% | $571.59M+91.3% | ||
| $400K-63.6% | —— | —— | —— | $1.1M-15.4% | ||
| $113.37M-20.9% | $144.45M+1.1% | $161.59M+12.6% | $164.87M+30.2% | $143.24M+49.5% | ||
| $121.87M+21.6% | $118.19M-1.1% | $150.65M+21.8% | $133.02M+25.3% | $100.23M+59.1% | ||
| $400K-63.6% | —— | —— | —— | $1.1M-15.4% | ||
| $300K-50.0% | —— | —— | —— | $600K+100% | ||
| $0-100% | $15M-25.9% | $2.5M-80.3% | $1.27M-69.2% | $596K-94.4% | ||
| 30,000,000%-30,000,000% | —— | —— | —— | 60,000,000%+30,000,000% | ||
| $60.62M+66.9% | —— | $36.31M-48.9% | $36.31M-48.9% | $36.31M-48.9% | ||
| $1.24B+131% | $1.24B— | $538.2M0.0% | $538.2M0.0% | $538.2M0.0% | ||
| $35.3M+8.3% | $37.7M+10.3% | $30.85M-10.6% | $31.92M-8.3% | $32.59M-9.9% | ||
| $951.96M+184% | $981.47M— | $299.84M-19.2% | $317.61M-18.3% | $335.37M-17.5% | ||
| $951.96M+148% | $981.47M+144% | $348.54M-16.9% | $366.31M-16.2% | $384.07M-15.6% | ||
| $35.3M+8.3% | $37.7M+10.3% | $30.85M-10.6% | $31.92M-8.3% | $32.59M-9.9% | ||
| $15.29M+3.8% | $10.93M-37.2% | $17.95M+8.3% | $21.38M+0.4% | $14.73M+13.7% | ||
| $82.23M+12.9% | $82.14M+9.5% | $71.42M-4.1% | $71.52M-4.6% | $72.82M-6.7% | ||
| $82.15M+21.8% | $77.6M+17.1% | $71.63M+12.3% | $68.81M+10.2% | $67.45M+7.0% | ||
| $35.3M+8.3% | $37.7M+10.3% | $30.85M-10.6% | $31.92M-8.3% | $32.59M-9.9% | ||
| $50.92M-8.4% | $53.55M-33.6% | $55.7M-30.5% | $56.37M+7.4% | $55.61M+221% | ||
| $140.37M+7.7% | $156.19M+21.2% | $111.18M+15.3% | $115.59M-2.0% | $130.31M+10.1% | ||
| $44.55M-15.9% | $46.59M-14.6% | $48.44M+8.3% | $55.06M+29.1% | $52.94M+32.6% | ||
| $140.37M+7.7% | $156.19M+21.2% | $111.18M+15.3% | $115.59M-2.0% | $130.31M+10.1% | ||
| $6.6M+633% | $7.7M— | $8.5M+347% | $9.9M— | $900K— | ||
| $6.6M+633% | $7.7M— | $8.5M+347% | $9.9M+1,314% | $900K+80.0% | ||
| $246.82M+32.2% | $270.06M+47.1% | $182.98M+33.7% | $193.36M+30.3% | $186.74M+24.9% | ||
| $2.18B+41.7% | $2.18B+41.7% | $1.54B+0.3% | $1.54B+0.3% | $1.54B+0.3% | ||
| $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| 118.5M-3.8% | 117.8M-4.3% | 117.5M-7.6% | 117.6M-7.0% | 123.2M-3.2% | ||
| 20M0.0% | 20M0.0% | 20M0.0% | 20M0.0% | 20M0.0% | ||
| 0— | 0— | 0— | 0— | 0— | ||
| 0— | 0— | 0— | 0— | 0— | ||
| $27.39M+261% | $12M— | $23.91M-61.4% | $0-100% | $7.6M-35.6% | ||
| $118K-4.1% | $118K-4.1% | $118K-7.1% | $118K-7.1% | $123K-3.1% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $8.9M-97.4% | —— | $63M-14.9% | $280.8M-11.0% | $340.9M+58.2% | ||
| $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| $0-100% | $0-100% | $277K-81.4% | $287K+28,600% | $448K+1,079% | ||
| $5K-98.9% | $2K-99.7% | $15K-75.0% | $337K+8.7% | $462K+135% | ||
| -$6.2M— | —— | -$8.5M— | -$9.9M— | —— | ||
| $82.15M+21.8% | $77.6M+17.1% | $71.63M+12.3% | $68.81M+10.2% | $67.45M+7.0% | ||
| $468.25M+50.3% | $450.88M+42.1% | $353.84M+21.0% | $323.7M+46.4% | $311.6M+54.2% | ||
| $10.26M+46.9% | $9.61M+9.9% | $7.8M+18.4% | $7.36M+11.3% | $6.98M+12.4% | ||
| $106.45M+88.6% | $113.86M+108% | $71.8M+77.7% | $77.77M+155% | $56.44M+80.9% | ||
| $9.11M+22.0% | $11.78M-29.4% | $8.43M-24.6% | $9.96M-26.3% | $7.47M-72.8% | ||
| $5K-98.9% | $2K-99.7% | $15K-75.0% | $337K+8.7% | $462K+135% | ||
| $0-100% | $0-100% | $277K-81.4% | $287K+28,600% | $448K+1,079% | ||
| $0-100% | $0-100% | $30.85M-85.4% | $113.07M+210% | $130.71M+105% | ||
| $8.87M-98.0% | $9M-97.1% | $251.44M-16.6% | $373.25M+22.5% | $440.89M+87.6% | ||
| $00.0% | $00.0% | $00.0% | $00.0% | $00.0% | ||
| $300M0.0% | $300M0.0% | $300M0.0% | $300M0.0% | $300M0.0% | ||
| $118.52M-3.8% | $117.78M-4.3% | $117.52M-7.6% | $117.62M-7.0% | $123.17M-3.2% | ||
| $118.52M-3.8% | $117.78M-4.3% | $117.52M-7.6% | $117.62M-7.0% | $123.17M-3.2% | ||
| $0-100% | $15M-25.9% | $2.5M-80.3% | $1.27M-69.2% | $596K-94.4% | ||
| $32.95M+258% | $35.48M+243% | $8.37M-8.3% | $8.37M+72.4% | $9.21M+101% | ||
| $44.55M-15.9% | $46.59M-14.6% | $48.44M+8.3% | $55.06M+29.1% | $52.94M+32.6% | ||
| $0— | —— | $0— | $0— | $0— | ||
| $8.88M-98.4% | $9M-98.1% | $282.04M-44.8% | $486.37M+42.4% | $571.61M+91.2% | ||
| $8.87M-98.4% | $9M-98.1% | $282.3M-44.9% | $486.32M+42.5% | $571.59M+91.3% | ||
| $8.9M-97.4% | —— | $63M-14.9% | $280.8M-11.0% | $340.9M+58.2% | ||
| $47.53M— | $42.92M— | $8.22M-31.2% | —— | —— | ||
| $300K-50.0% | —— | —— | —— | $600K+100% | ||
| $10.5M+289% | $15.1M— | $19.4M+223% | $24.9M+3,457% | $2.7M+440% | ||
| $483.39M+1,382% | —— | $32.62M-52.7% | $32.62M-52.7% | $32.62M-52.7% | ||
| $291.25M+43.6% | $261.73M— | $238.36M+42.5% | $220.59M+47.5% | $202.83M+53.9% | ||
| $118.05M+66.2% | —— | $71.05M0.0% | $71.05M0.0% | $71.05M0.0% | ||
| $60.62M+66.9% | —— | $36.31M-48.9% | $36.31M-48.9% | $36.31M-48.9% | ||
| $88.54M+66.1% | —— | $17.76M0.0% | $35.53M0.0% | $53.29M0.0% | ||
| $118.05M+66.2% | —— | $71.05M0.0% | $71.05M0.0% | $71.05M0.0% | ||
| $83.31M+17.3% | —— | $71.05M0.0% | $71.05M0.0% | $71.05M0.0% | ||
| $1.24B+131% | $1.24B— | $538.2M0.0% | $538.2M0.0% | $538.2M0.0% | ||
| $170.31M-14.1% | $197.24M+0.1% | $215.39M+14.0% | $213.59M+12.1% | $198.31M— | ||
| $00.0% | $00.0% | $00.0% | $00.0% | $00.0% | ||
| $20M0.0% | $20M0.0% | $20M0.0% | $20M0.0% | $20M0.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $75.29M+79.3% | $71.93M+98.0% | $56.03M+80.4% | $50.13M+62.1% | $41.99M+16.0% | ||
| $5.7M+613% | —— | $0-100% | $0-100% | $800K-33.3% | ||
| $88.54M+66.1% | —— | $17.76M0.0% | $35.53M0.0% | $53.29M0.0% | ||
| $88.54M+66.1% | —— | $17.76M0.0% | $35.53M0.0% | $53.29M0.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Halozyme Therapeutics's total assets?
- Halozyme Therapeutics (HALO) holds $2.7B in total assets, up 21.7% year over year.
- How much debt does Halozyme Therapeutics have?
- Halozyme Therapeutics carries $2.2B in total debt against $219.6M of shareholders' equity, a debt-to-equity ratio of 9.91.
- How much cash does Halozyme Therapeutics have?
- Halozyme Therapeutics holds $312.0M in cash and equivalents.
- Can Halozyme Therapeutics cover its short-term obligations?
- Its current ratio is 2.76 — current assets exceed current liabilities.
- Where does Halozyme Therapeutics's balance sheet data come from?
- Every line is extracted from Halozyme Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
